Caredx Inc (CDNA)’s Market Momentum: Closing Strong at 24.91, Down -0.82

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Caredx Inc’s stock clocked out at $24.91, down -0.82% from its previous closing price of $25.11. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 0.65 million shares were traded. CDNA stock price reached its highest trading level at $25.85 during the session, while it also had its lowest trading level at $24.545.

Ratios:

To gain a deeper understanding of CDNA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1086.16. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.

On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when PETER MAAG bought 5,000 shares for $24.11 per share.

JEFFREY NOVACK bought 1,223 shares of CDNA for $28,288 on Nov 25 ’24. On Nov 18 ’24, another insider, JEFFREY NOVACK, who serves as the Officer of the company, bought 5,534 shares for $21.17 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1336020480 and an Enterprise Value of 1125131776. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.24 while its Price-to-Book (P/B) ratio in mrq is 4.84. Its current Enterprise Value per Revenue stands at 3.597 whereas that against EBITDA is -25.424.

Stock Price History:

Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -3.29%, while the 200-Day Moving Average is calculated to be 34.05%.

Shares Statistics:

It appears that CDNA traded 850.04K shares on average per day over the past three months and 811520 shares per day over the past ten days. A total of 51.50M shares are outstanding, with a floating share count of 50.16M. Insiders hold about 6.48% of the company’s shares, while institutions hold 97.23% stake in the company. Shares short for CDNA as of 1731628800 were 3071080 with a Short Ratio of 3.61, compared to 1728950400 on 3476043. Therefore, it implies a Short% of Shares Outstanding of 3071080 and a Short% of Float of 7.550000399999999.

Most Popular